Vision Weekend is the Foresight Institute's flagship frontier-technology gathering, and the USA edition runs for three days in San Francisco. Longevity biotech is one of its central tracks, alongside nanotechnology, neurotechnology, space and AI for science.
Foresight has funded and convened work at the speculative edge of science since the 1980s, and Vision Weekend reflects that: the density of researcher-builders — people who both publish and start companies — is unusually high, and the format favours working sessions, demos, unconference slots and small-group discussion over long plenary lectures. The longevity track typically covers cellular reprogramming, senescence, organ and tissue replacement, cryobiology and biostasis, molecular machines for biology, brain ageing, and the measurement problem of proving that an intervention slows ageing in humans.
This is not a clinical meeting and does not pretend to be. It is where early-stage ideas, funding and technical talent meet, several years upstream of anything that reaches a clinic. That makes it valuable for researchers choosing what to work on, for investors looking at the earliest end of the pipeline, and for clinicians who want to understand what is genuinely coming versus what is being marketed as imminent.
For research-active physicians and biomedical scientists in Saudi Arabia and the Gulf, Vision Weekend offers a view of the field's frontier that is difficult to get from published literature alone, at a moment when regional institutions are actively funding ageing research and building translational capacity.
Attendance is typically application-based or invitation-weighted, with limited capacity and tiered ticketing, and San Francisco in November books out early. Registration criteria, the agenda and the speaker roster are published by Foresight Institute; anyone planning to attend should apply well ahead and confirm arrangements directly with the organisers.
